Chinese Research Body Says Gilead Infringed COVID Patent
A Chinese military medical research institute has accused Gilead at a London court of infringing its patent for a COVID-19 treatment, hitting back at the biopharmaceutical company's recent attempt to void...To view the full article, register now.
Already a subscriber? Click here to view full article